Corvia Medical, Inc.

Corvia Medical, Inc. company information, Employees & Contact Information

Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia® Atrial Shunt is the world’s first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction. Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Ventures, Edward Lifesciences and an undisclosed strategic investor. In the United States, the Corvia Atrial Shunt System is an investigational device and not available for commercial distribution or sale.

Company Details

Employees
38
Founded
-
Address
One Highwood Drive,
Phone
978-654-6123
Email
in****@****cal.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Tewksbury, MA
Looking for a particular Corvia Medical, Inc. employee's phone or email?

Corvia Medical, Inc. Questions

News

Corvia Medical Closes $55 Million Funding Round - citybiz

Corvia Medical Closes $55 Million Funding Round citybiz

Corvia Medical raises $55M as it seeks FDA nod for atrial shunt - MassDevice

Corvia Medical raises $55M as it seeks FDA nod for atrial shunt MassDevice

Corvia Medical raises $55m to complete confirmatory heart shunt trial - Medical Device Network

Corvia Medical raises $55m to complete confirmatory heart shunt trial Medical Device Network

Corvia Medical: $55 Million Raised For Treating Heart Failure - Pulse 2.0

Corvia Medical: $55 Million Raised For Treating Heart Failure Pulse 2.0

CORVIA MEDICAL CLOSES $54 MILLION FINANCING TO SUPPORT PLANNED CONFIRMATORY TRIAL OF THE CORVIA® ATRIAL SHUNT - PR Newswire

CORVIA MEDICAL CLOSES $54 MILLION FINANCING TO SUPPORT PLANNED CONFIRMATORY TRIAL OF THE CORVIA® ATRIAL SHUNT PR Newswire

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data - Diagnostic and Interventional Cardiology

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data Diagnostic and Interventional Cardiology

Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients - PR Newswire

Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients PR Newswire

Corvia Medical raises $54M to continue studying implantable heart failure treatment - Cardiovascular Business

Corvia Medical raises $54M to continue studying implantable heart failure treatment Cardiovascular Business

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS - aap.com.au

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS aap.com.au

WilmerHale Guides Corvia Medical in $35M Strategic Investment by Edwards Lifesciences - WilmerHale

WilmerHale Guides Corvia Medical in $35M Strategic Investment by Edwards Lifesciences WilmerHale

Corvia Medical Secures $55M to Pursue FDA Nod for Atrial Shunt - Medical Product Outsourcing

Corvia Medical Secures $55M to Pursue FDA Nod for Atrial Shunt Medical Product Outsourcing

Corvia Medical InterAtrial shunt device receives CE mark - Cardiac Rhythm News

Corvia Medical InterAtrial shunt device receives CE mark Cardiac Rhythm News

Corvia Medical has positive data for atrial shunt - MassDevice

Corvia Medical has positive data for atrial shunt MassDevice

Corvia Medical's Interatrial Shunt Device (IASD®) Receives Breakthrough Device Designation For Heart Failure - PR Newswire

Corvia Medical's Interatrial Shunt Device (IASD®) Receives Breakthrough Device Designation For Heart Failure PR Newswire

Corvia Medical’s atrial shunt therapy shows promise in randomised clinical trial - Medical Device Network

Corvia Medical’s atrial shunt therapy shows promise in randomised clinical trial Medical Device Network

Corvia Medical Enters Into Agreement With Edwards Lifesciences, The Global Leader In Structural Heart Innovation - PR Newswire

Corvia Medical Enters Into Agreement With Edwards Lifesciences, The Global Leader In Structural Heart Innovation PR Newswire

Corvia Medical’s atrial shunt trial fails primary endpoint - MassDevice

Corvia Medical’s atrial shunt trial fails primary endpoint MassDevice

Corvia Medical launches Interatrial Shunt Device heart failure trial - MassDevice

Corvia Medical launches Interatrial Shunt Device heart failure trial MassDevice

Corvia Medical touts 1-year data for InterAtrial shunt - MassDevice

Corvia Medical touts 1-year data for InterAtrial shunt MassDevice

Corvia Medical lands CE Mark for heart shunt - MassDevice

Corvia Medical lands CE Mark for heart shunt MassDevice

Top Corvia Medical, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant